Revolution Medicines (RVMD) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to 0.71.
- Revolution Medicines' Equity Ratio fell 2018.18% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year decrease of 2018.18%. This contributed to the annual value of 0.89 for FY2024, which is 3.79% down from last year.
- Revolution Medicines' Equity Ratio amounted to 0.71 in Q3 2025, which was down 2018.18% from 0.77 recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Equity Ratio registered a high of 0.9 during Q1 2024, and its lowest value of 0.71 during Q3 2025.
- Its 5-year average for Equity Ratio is 0.85, with a median of 0.87 in 2021.
- In the last 5 years, Revolution Medicines' Equity Ratio skyrocketed by 1143.96% in 2021 and then crashed by 2018.18% in 2025.
- Quarter analysis of 5 years shows Revolution Medicines' Equity Ratio stood at 0.82 in 2021, then grew by 3.36% to 0.84 in 2022, then increased by 4.96% to 0.89 in 2023, then dropped by 0.04% to 0.89 in 2024, then fell by 19.91% to 0.71 in 2025.
- Its last three reported values are 0.71 in Q3 2025, 0.77 for Q2 2025, and 0.88 during Q1 2025.